Martyn Kim Robinson

This inventor holds 13 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 11 EPO patents. Top assignees: Ucb Pharma, S.a., Amgen Inc., Biogen Idec Ma Inc.. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martyn Kim Robinson. Retrieved from https://idiyas.com/inventor/martyn-kim-robinson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 3)

% Patents Active = 84.6

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 11 (Patent Applications = 5)

Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 189(Granted Patents)

Location History:

Wooburn Green, GB (2009 - 2011)
High Wycombe, GB (2010 - 2011)
Woodburn Green, GB (2011)
Slough, GB (2012)
Berkshire, GB (2014 - 2016)
Buckinghamshire, GB (2018)
Shaftesbury, GB (2020 - 2024)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2009-2026

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12667615 - TREATMENT FOR BONE DISEASES (2026-06-30),

2. 11896667 - Treatment for bone diseases (2024-02-13),

3. 11851483 - Anti-sclerostin antibodies and their use to treat bone disorders as part of a regimen (2023-12-26),

4. 10799583 - Treatment for bone diseases (2020-10-13),

5. 9925260 - Treatment for bone diseases (2018-03-27),

6. 9321840 - Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof (2016-04-26),

7. 8784823 - Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof (2014-07-22),

8. 8293237 - Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof (2012-10-23),

9. 8003108 - Sclerostin epitopes (2011-08-23),

10. 7931900 - Method for the treatment of multiple sclerosis by inhibiting IL-17 activity (2011-04-26),

11. 7872106 - Sclerostin-binding antibodies (2011-01-18),

12. 7662609 - [object Object] (2010-02-16),

13. 7592429 - Sclerostin-binding antibody (2009-09-22),

Title: The Innovative Journey of Martyn Kim Robinson

Introduction:

Martyn Kim Robinson, a pioneering inventor hailing from Berkshire, GB, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents:

Martyn Kim Robinson's latest patents include cutting-edge technologies in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach.

Career Highlights:

With a career spanning over two decades, Martyn Kim Robinson has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His patents have revolutionized industries and improved the lives of many around the globe.

Collaborations:

Throughout his career, Martyn Kim Robinson has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work in multidisciplinary teams has led to the successful implementation of groundbreaking technologies.

Conclusion:

In conclusion, Martyn Kim Robinson's passion for innovation, coupled with his dedication to pushing the boundaries of what is possible, has solidified his position as a trailblazing inventor in the world of technology. His relentless pursuit of excellence continues to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.